Chong Kun Dang Pharmaceutical Corp.(KR:185750)
₩61,300.00-3300.00 (-5.11%)
KR:185750
Chong Kun Dang Pharmaceutical Corp. financials statements
₩61,300.00
At close:-3300.00 (-5.11%)
Want to see KR:185750 full AI Analyst Report?
Chong Kun Dang Pharmaceutical Corp. (185750) Income Statement
1 Followers
Chong Kun Dang Pharmaceutical Corp. Income Statement
Last quarter (Q2 2026), Chong Kun Dang Pharmaceutical Corp.'s total revenue was ₩478.47B, an increase of 10.03% from the same quarter last year. In Q2, Chong Kun Dang Pharmaceutical Corp.'s net income was ₩19.99B. See Chong Kun Dang Pharmaceutical Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 1.69T | ₩ 1.59T | ₩ 1.67T | ₩ 1.49T | ₩ 1.34T | |
| ₩ 517.23B | ₩ 532.61B | ₩ 662.20B | ₩ 542.64B | ₩ 495.82B | |
| ₩ 436.56B | ₩ 433.15B | ₩ 415.60B | ₩ 432.73B | ₩ 401.06B | |
| Depreciation and Amortization | ₩ 44.69B | ₩ 39.77B | ₩ 37.03B | ₩ 33.60B | ₩ 27.48B |
| ₩ 125.37B | ₩ 150.10B | ₩ 287.62B | ₩ 137.61B | ₩ 112.71B | |
| ₩ 80.57B | ₩ 99.46B | ₩ 246.60B | ₩ 109.91B | ₩ 94.76B | |
| ₩ 1.08B | ₩ 2.55B | ₩ -5.00B | ₩ -12.74B | ₩ -14.16B | |
| ₩ 81.65B | ₩ 102.01B | ₩ 241.60B | ₩ 97.17B | ₩ 80.59B | |
| ₩ 77.83B | ₩ 109.07B | ₩ 212.52B | ₩ 80.95B | ₩ 42.72B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ 5882.09 | ₩ 8206.52 | ₩ 16704.00 | ₩ 6608.77 | ₩ 3117.59 |
| Diluted EPS | ₩ 5845.54 | ₩ 8206.52 | ₩ 16704.00 | ₩ 6608.77 | ₩ 3117.59 |
| Weighted Average Shares Outstanding | 13.18M | 13.25M | 12.72M | 12.25M | 12.44M |
| Weighted Average Shares Outstanding (Diluted) | 13.18M | 13.25M | 12.72M | 12.25M | 12.44M |
Currency in KRW

